S&P 500   2,993.14 (-0.08%)
DOW   26,999.62 (-0.09%)
QQQ   193.15 (-0.19%)
AAPL   234.00 (-0.56%)
FB   187.57 (-0.70%)
MSFT   140.18 (-0.98%)
GOOGL   1,248.24 (+0.48%)
AMZN   1,781.47 (+0.80%)
CGC   19.37 (-3.63%)
NVDA   198.77 (+1.22%)
MU   46.38 (-0.17%)
GE   8.97 (+0.90%)
AMD   31.15 (+1.40%)
T   37.96 (+0.16%)
ACB   3.63 (-3.45%)
PRI   125.41 (+1.41%)
NFLX   284.16 (-0.03%)
BAC   30.32 (+1.98%)
GILD   65.38 (+0.12%)
DIS   130.59 (+0.64%)
S&P 500   2,993.14 (-0.08%)
DOW   26,999.62 (-0.09%)
QQQ   193.15 (-0.19%)
AAPL   234.00 (-0.56%)
FB   187.57 (-0.70%)
MSFT   140.18 (-0.98%)
GOOGL   1,248.24 (+0.48%)
AMZN   1,781.47 (+0.80%)
CGC   19.37 (-3.63%)
NVDA   198.77 (+1.22%)
MU   46.38 (-0.17%)
GE   8.97 (+0.90%)
AMD   31.15 (+1.40%)
T   37.96 (+0.16%)
ACB   3.63 (-3.45%)
PRI   125.41 (+1.41%)
NFLX   284.16 (-0.03%)
BAC   30.32 (+1.98%)
GILD   65.38 (+0.12%)
DIS   130.59 (+0.64%)
Log in

vTv Therapeutics Price Target & Analyst Ratings (NASDAQ:VTVT)

$1.46
+0.03 (+2.10 %)
(As of 10/16/2019 10:32 AM ET)
Today's Range
$1.46
Now: $1.46
$1.46
50-Day Range
$1.28
MA: $1.45
$1.76
52-Week Range
$1.00
Now: $1.46
$4.59
Volume201 shs
Average Volume400,182 shs
Market Capitalization$79.03 million
P/E RatioN/A
Dividend YieldN/A
Beta-3.61

Analyst Ratings

vTv Therapeutics (NASDAQ:VTVT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for vTv Therapeutics in the last 12 months. Their average twelve-month price target is $6.50, suggesting that the stock has a possible upside of 345.21%. The high price target for VTVT is $8.00 and the low price target for VTVT is $5.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 3.003.003.002.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.50$6.50$6.50$3.00
Price Target Upside: 345.21% upside415.87% upside354.55% upside54.64% upside

vTv Therapeutics (NASDAQ:VTVT) Consensus Price Target History

vTv Therapeutics (NASDAQ:VTVT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/9/2019Northland SecuritiesSet Price TargetBuy$8.00Low
8/16/2019HC WainwrightReiterated RatingBuy$5.00High
4/10/2018Roth CapitalDowngradeBuy ➝ Neutral$18.00 ➝ $17.00High
4/10/2018Seaport Global SecuritiesDowngradeBuy ➝ NeutralHigh
4/10/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$4.00High
4/10/2018Stifel NicolausDowngradeBuy ➝ HoldHigh
12/21/2017Canaccord GenuitySet Price TargetBuy$15.00Low
11/8/2017CitigroupReiterated RatingaddN/A
(Data available from 10/16/2017 forward)
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: High-Yield Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel